CD96 and glioma: Subsequent analysis revealed increased expression of CD96 in higher grade glioma in TCGA-LGG cohort [consistent with our previous study (35)], but in lower stage melanoma in TCGA-SKCM cohort, showing significantly different expression distributions in LGG and SKCM.